Superbugs
AMR Action Fund raises $140m from new investors to tackle antimicrobial resistance
New investment adds to initial $1bn raised at the Fund's launch last year
Sandoz to acquire GSK’s cephalosporin antibiotic brands for up to $500m
Sandoz, the generics division of Novartis, will pay $350m upfront for three established brands
Mallinckrodt files for bankruptcy protection in the US
Bankruptcy filing will reduce debts related to legal liabilities
Antibiotic biotech Melinta files for bankruptcy
Worries over antibiotic business model continue to mount
GSK takes new-class antibiotic into phase 3 for serious infections
Could provide a much-needed option for treatment-resistant infections
Untreatable gonorrhoea on the march worldwide, says WHO
Three people with the STI aren’t responding to last-line antibiotics
Basilea’s novel antibiotic reaches UK market
Zevtera can be used against a range of infections including MRSA
Actavis gets FDA nod for new antibiotic
Avycaz is the fifth antibiotic to gain US approval in recent months
Dendreon to go to auction without initial bidder
A selection for a bidder wanting to pay the minimum price has not been made
